Neurosurgery Navigation & Therapy - Disposable Products was ClearPoint Neuro’s largest product and service line in fiscal 2025, bringing in $14.83M of $36.97M (40%).
| Product and Service | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Neurosurgery Navigation & Therapy - Disposable Products | — | $7.59M | $10.29M | $14.83M | ||||
| Biologics & Drug Delivery - Services And License Fees | $5.43M | $11.45M | $11.70M | $11.70M | ||||
| Functional Neurosurgery Navigation & Therapy - Disposable Products | $7.59M | — | — | — | ||||
| Product - Product Revenue | — | — | — | — | ||||
| Subtotal - Functional Neurosurgery Navigation & Therapy | — | — | — | — | ||||
| Biologics & Drug Delivery - Disposable Products | $3.69M | $2.15M | $5.61M | $7.34M | ||||
| Biologics & Drug Delivery - Services | — | — | — | — | ||||
| Functional Neurosurgery Navigation & Therapy - Services | $1.54M | — | — | — | ||||
| Capital Equipment & Software - Systems And Software Products | $1.51M | $860.00K | $2.74M | $1.69M | ||||
| Neurosurgery Navigation & Therapy - Services | — | $931.00K | — | — | ||||
| Capital Equipment & Software - Services | $795.00K | $973.00K | $1.06M | $1.41M | ||||
| Services - Capital Equipment & Other | — | — | — | — | ||||
| Services - Biologics & Drug Delivery | — | — | — | — | ||||
| Service - Therapy | — | — | — | — | ||||
| Total | $20.55M | $23.96M | $31.39M | $36.97M |
ClearPoint Neuro brought in $36.97M from its five product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 17.8% from $31.39M in fiscal 2024. Neurosurgery Navigation & Therapy - Disposable Products was the largest at $14.83M (40.1%), ahead of Biologics & Drug Delivery - Services And License Fees at $11.70M (31.7%) and Biologics & Drug Delivery - Disposable Products at $7.34M (19.8%). The other two lines brought in $3.10M combined.
Compared with fiscal 2024, Neurosurgery Navigation & Therapy - Disposable Products grew fastest, up 44.2% to $14.83M, while Capital Equipment & Software - Systems And Software Products fell the most, down 38.2% to $1.69M.
ClearPoint Neuro began breaking out Neurosurgery Navigation & Therapy - Disposable Products in fiscal 2023, when it brought in $7.59M. ClearPoint Neuro stopped reporting Functional Neurosurgery Navigation & Therapy - Disposable Products ($7.59M in fiscal 2022), Functional Neurosurgery Navigation & Therapy - Services ($1.54M in fiscal 2022) and Neurosurgery Navigation & Therapy - Services ($931.00K in fiscal 2023) as separate lines.
ClearPoint Neuro (CLPT) reports its revenue by product and service. In fiscal 2025, Neurosurgery Navigation & Therapy - Disposable Products was its largest product and service line, bringing in $14.83M (40.1% of the total), followed by Biologics & Drug Delivery - Services And License Fees at $11.70M (31.7%).
Neurosurgery Navigation & Therapy - Disposable Products was ClearPoint Neuro's largest product and service line in fiscal 2025, bringing in $14.83M, or 40.1% of the $36.97M total across its five product and service lines.
Among ClearPoint Neuro's product and service lines that make up at least 2% of revenue, Neurosurgery Navigation & Therapy - Disposable Products grew fastest in fiscal 2025, up 44.2% from $10.29M to $14.83M.
Every figure comes from ClearPoint Neuro's annual financial filings, as reported. Each line keeps the name ClearPoint Neuro gives it, and years follow its fiscal calendar.
ClearPoint Neuro's revenue by product and service goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.